Literature DB >> 14556185

[46,XY female sex reversal patient with a novel point mutation in the coding sequence of the SRY gene].

Chang Zhou1, Lu-yun Li, Jun-jiang Fu, Ya-qin Mo, Chang-gao Zhong, Guang-xiu Lu.   

Abstract

OBJECTIVE: To investigate the molecular mechanism of a Chinese patient with 46, XY sex reversal.
METHODS: DNA fragments of the SRY gene from the typical XY female sex reversal patient and her father were amplified by polymerase chain reaction (PCR). The amplified PCR fragments were cloned into the pUCm-T vector, and direct sequencing was carried out on an ABI 377-3 automated DNA sequencer to detect the mutation. PCR-restriction enzyme digestion was applied to detect the results of DNA sequencing.
RESULTS: A novel mutation of the SRY gene was identified in the XY sex reversal patient of this study. A T is replaced by an A in codon 129 at position +387, resulting in the replacement of the polar amino acid tyrosine (TAT) by the stop code (TAA) in the HMG-box, whereas her father was proved to have the wild-type sequence. Because the mutation introduced an enzyme site of MaeIII, the PCR-restrict enzyme digestion showed that there were three bands (131 bp,231 bp and 247 bp) in the patient, whereas two bands (131 bp and 478 bp) in normal man. It verified the results of sequencing analysis. The results after searching the Human Gene Mutation Database showed that this mutation was not described before and should be a new mutation.
CONCLUSION: The novel mutation in SRY gene has provided valuable information for the understanding of molecular mechanism of the patient with 46,XY female sex reversal.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14556185

Source DB:  PubMed          Journal:  Zhonghua Yi Xue Yi Chuan Xue Za Zhi        ISSN: 1003-9406


  1 in total

1.  Analysis of SRY gene in 8 cases of sex abnormality.

Authors:  Hui Wang; Yun Teng; Hong Tian; Yanping Tang; Yan Chen; Zhenrong Yang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.